AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Optrigliz M 30mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Optrica Pharma Private Limited

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Optrigliz M 30mg/500mg Tablet

Diabetol Duo 30mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential to manage hypoglycemia. Alcohol consumption should be minimized due to its interaction with the medication. Other potential side effects encompass altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Uses of Optrigliz M 30mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Optrigliz M 30mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Optrigliz M 30mg/500mg Tablet should be administered with a meal.

Common Side effects of Optrigliz M 30mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Optrigliz M 30mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Optrigliz M 30mg/500mg Tablet with meals.

How Optrigliz M 30mg/500mg Tablet works:

Gliclazide and Metformin, combined in Optrigliz M 30mg/500mg tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Optrigliz M 30mg/500mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Optrigliz M 30mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing may occur exceptionally in life-threatening circumstances where potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Optrigliz M 30mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Optrigliz M 30mg/500mg tablets, as dose modification may be necessary. Medical advice is recommended. The use of Optrigliz M 30mg/500mg tablets is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Optrigliz M 30mg/500mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Optrigliz M 30mg/500mg Tablet :

Should you forget a dose of Optrigliz M 30mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Optrigliz M 30mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Optrigliz M 30mg/500mg Tablet

Optrigliz M 30mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Optrigliz M 30mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Optrigliz M 30mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Optrigliz M 30mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Optrigliz M and seek immediate medical attention.
Prolonged use of Optrigliz M 30mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Optrigliz M 30mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. The medication should also be avoided in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Optrigliz M 30mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Optrigliz M 30mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Optrigliz M 30mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Optrigliz M 30mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Optrigliz M 30mg/500mg Tablets can cause lactic acidosis (MALA), a serious, though rare, complication characterized by excessive blood lactic acid. This medical emergency is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Prolonged use of Optrigliz M 30mg/500mg tablets can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Optrigliz M 30mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Optrigliz M 30mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Optrigliz M 30mg/500mg Ta...
49
MRP 60
18% off